# ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.

Study · id `cardio:ct-nct04633265` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04633265](<https://clinicaltrials.gov/study/NCT04633265>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04633265

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT04633265. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-10 (actual); primary completion 2021-03-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT04633265, source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)
- Started: 2018-01-10 (actual) (ClinicalTrials.gov record NCT04633265, source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)
- Primary completion: 2021-03-31 (actual) (ClinicalTrials.gov record NCT04633265, source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)
- Completion: 2021-03-31 (actual) (ClinicalTrials.gov record NCT04633265, source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04633265, source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04633265-2024-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.
- Acronym: TARGET-AF2
- Condition: Atrial Fibrillation
- Intervention (Device): ECG-I Mapping of Atrial Fibrillation
- Lead sponsor: Barts & The London NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Barts & The London NHS Trust (`cardio:org-barts-the-london-nhs-trust`)

## Provenance

Content hash: 53bc8d5b4816d60533f2fef55c7505d89d07dbdf6da326af4702c756a18c81fe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
